Harvested bone marrow in preparation for transplant In terms of the management of<unk>  for those individuals with this condition the following can be applied: * Killed vaccines should be used(not live vaccines in<unk>  * Bone marrow transplant * Immunoglobulin replacement * Antiviral therapy * Supplemental nutrition Epidemiology In the U.S. this defect occurs in about 1 in 70,000, with the majority of cases presenting in early life. Furthermore, SCID has an incidence of approximately 1 in 66,000 in California.
T cell deficiency
IgG deficiency
Thymic hypoplasia
Humoral immune deficiency
Combined immunodeficiencies
Primary immunodeficiency
Leukocyte adhesion molecule deficiency
Leukocyte adhesion deficiency